Spinal cord injury treatment with injected cells
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study tests a new treatment for spinal cord injury that is given through a spinal tap. It is for people with a recent or past spinal cord injury who are at least 18 years old. The treatment may help improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- Your spinal cord injury was caused by a blow or impact, not a sharp cut or disease
- Your injury is at or below the C2 level (below the top of the spine)
- Your injury happened within the last 10 years
- You have not had stem cell, gene, or exosome treatments before
- You are not pregnant, and if you could become pregnant, you agree to use birth control for a year after treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new cell therapy (XS228) can help people with recent spinal cord injuries recover function. The cells are given through a spinal tap and are designed to replace damaged nerve cells.
This trial tests a combination of stem cells injected into the spinal fluid and a non-invasive spinal cord stimulation device to see if they can improve recovery after a spinal cord injury. It is for people who have had a single traumatic injury between neck and mid-back, 1 to 5 years ago, and are in stable health.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
This study tests whether stem cell treatment along with virtual reality–based training can improve function after spinal cord injury that is not expected to recover with standard care. It’s designed for adults who are medically stable and can safely complete follow-up assessments.
This trial tests a device that delivers a special cell therapy (LCTOPC1) into the spinal cord. It is for people with a recent or chronic spinal cord injury that is severe (no feeling or movement below the injury) or leaves some sensation but no movement.
This study looks at how spinal cord stimulation affects long-term recovery and daily functioning in people with stable spinal cord injury. You may be eligible if you already have an implanted, FDA-approved spinal cord stimulator and meet specific safety and timing rules.
Hear when a new SCI - Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.